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TO THE EDITOR
Since the introduction of cytogenetic analyses into the study of
plasma cell neoplasias, it has been repeatedly shown that
multiple myeloma (MM) is a heterogeneous disease with regard
to the underlying chromosomal abnormalities. In a very recent
issue of Leukemia, Debes-Marun et al1 applied statistical cluster
analyses towards the abnormal karyotypes of 254 myelomas
from the Mayo Clinic (Rochester, MN, USA). By this novel
approach, they were able to identify recurrent patterns of
chromosomal changes and to define cytogenetic subgroups of
the disease.
We recently analyzed the karyotypes of 276 cases of MM
from European institutions with statistical methods similar to
those applied by Debes-Marun et al.1 In all, 138 karyotypes
(including 72 published in Calasanz et al 2) were retrieved from
the cytogenetic database of the Department of Genetics in
Pamplona (Spain). Moreover, 138 karyotypes from another
published European series3 were included. The population
studied by us is, thus, completely independent of the series
studied by Debes-Marun et al,1 and therefore constitutes a
proper statistical validation set. Only MM with abnormal
karyotypes were considered and those patients with a diagnosis
of a secondary neoplasia were excluded. The presence or
absence of chromosomal aberrations was recorded in all cases.
A total of 30 recurrent cytogenetic variables present in more
than 5% of the cases entered the statistical analyses, from which
at least one was present in 250 cases.
Due to the nature of the variables, average linkage
hierarchical clustering with three methods for computing
distances, that is, Jaccard’s, Dice’s and Sokal’s coefficients,
were performed using the Stata, Clustan and SPSS software
packages. The cluster trees derived from the three approxima-
tions were closely related (data not shown). Thus, from the
statistical point of view, the methods applied in the present
study and by Debes-Marun et al,1 who used Jaccard’s an
Kendall’s tau coefficients, are completely comparable.
Our results (Figure 1a) are in excellent concordance with
those published by Debes-Marun et al.1 One cluster was
characterized by hypodiploidy and included complete or partial
losses of chromosomes X, 1, 2, 4, 5, 6, 8, 11, 13, 14, 16, 17, 20,
21 and 22. This cytogenetic cluster, besides the losses of
chromosome 13 (51/76 cases in this cluster), also contained
structural abnormalities in 14q32 (19/76 cases in this cluster)
and 22q (29/76 cases in this cluster), suggestive for transloca-
tions involving the immunoglobulin genes, IGH and IGL,
respectively. Translocations involving IGH might also be hidden
in the cases with monosomy 14 (32/76 cases in this cluster),
which may indicate the loss of the der(14) from a cryptic IGH
translocation as has been reported to be recurrent in
t(4;14)(p16;q32).4 A second major cytogenetic branch was
characterized by a hyperdiploid karyotype due to multiple
trisomies (gains or partial gains of chromosomes 3, 5, 7, 9, 11,
15, 19 and 21). The 95 cases assigned to this cytogenetic cluster
only rarely contained breakpoints in 14q32 (9/95 cases). The
incidence of cytogenetic 14q32 breakpoints and monosomy 13
in the hyperdiploid subgroup was significantly lower than in the
hypodiploid cluster (9/95 vs 19/76, P¼ 0.006 and 19/95 vs 51/
76, Po0.001, respectively, by Fisher’s exact test). Moreover, the
frequency of appearance of monosomy 14 and 22q abnormal-
ities, suggesting the presence of IG rearrangements, was also
significantly lower in the hyperdiploid branch (8/95 vs 32/76,
Po0.001 and 7/95 vs 29/76, Po0.001, respectively). A third
major cytogenetic branch was characterized predominantly by
structural aberrations in 14q32, but wide lack of a considerable
number of chromosomal losses. Out of 49 MM assigned to this
cluster, 37 carried 14q32 aberrations.
Thus, clustering of cytogenetic abnormalities in MM reveals
two clusters with frequent IG translocations with and without
marked hypodiploidy as well as a distinct hyperdiploid cluster.
In addition, minor cytogenetic clusters might exist, such as MM
with duplications in 1q or loss of the Y chromosome. Never-
theless, the biological meaning of these minor clusters warrants
further investigations.
Whereas it can be assumed that IG-driven oncogene
activation is the major underlying genetic change in the
nonhyperdiploid clusters, the genetic basis of the hyperdiploid
MM group is widely unknown. Besides the rarity of recurrent
translocations, this group is characterized by trisomies of mostly
structurally intact chromosomes as well as a comparably
favorable prognosis.3–5 Remarkably, another lymphocyte-
Figure 1 Bidimensional hierarchical cluster analyses (using
Jaccard’s distance measurement) of chromosome abnormalities.
Alterations are plotted along the top horizontal axis and tumor
samples along the vertical axis. Chromosome aberrations are arranged
in a dendrogram, which groups alterations by their frequency of
coappearance. Tumor samples are arranged in the same way along the
vertical axis, and those cases with the most similar patterns of
chromosome aberrations are adjacent to each other. Black cells
indicate the absence of alteration, whereas colored cells indicate the
presence of a given chromosomal abnormality: red cells indicate the
presence of chromosomal gains; green cells, chromosomal losses; dark
blue cells, 14q32 aberrations; light blue cells, deletion 22q and
monosomy 14 (suggestive of IG rearrangements); white cells,
nonresolved aberrations. (a) The analysis of 250 MM cases carrying
at least one of the cytogenetic variables under study. Variables defined
as partial chromosome gains or losses include also trisomies or
monosomies of the complete chromosome, for example, trisomy 3 is
included in the variable DUP3Q. The branch marked in red contains
partial or complete chromosomal gains characteristic of hyperdiploid
MM. Partial or complete chromosomal losses, typical of hypodiploid
MM, are colored in green. Along the vertical axis, cases colored in red
and green are the hyperdiploid and hypodiploid respectively, whereas
cases colored in blue indicate the cluster defined by 14q32 aberrations
and wide lack of numerical changes. (b) Different patterns of complete
chromosome gains (defined by the presence of the centromere)
between hyperdiploid MM and ALL variants. Along the vertical axis,
cluster marked in red is characterized by hyperdiploid MM, whereas
the branch colored in yellow groups ALL cases by their trisomies
pattern.
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derived neoplasia is characterized by the very same features,
namely, hyperdiploid acute lymphoblastic leukemia (ALL) with
more than 50 chromosomes.6 This subtype of ALL, also
recognized as a distinct entity by the WHO classification of
hematologic neoplasia,7 comprises approximately 20–25% of
ALL and displays a characteristic gene expression profile.8 It is
intriguing to speculate that hyperdiploid MM and ALL may have
in common a similar pathogenic mechanisms leading to the
multiple chromosomal trisomies.
In order to compare the pattern of chromosomal gains
between the hyperdiploid variants of MM and ALL, we
performed clustering of karyotypes from these neoplasms. Based
on the definition of hyperdiploid ALL by the WHO classifica-
tion,7 only those tumors entered this analysis, which contained
more than 50 chromosomes (chromosomal gains defined by the
presence of the respective centromere) and lacked any typical
structural aberration like breakpoints in IG loci in MM or
t(9;22)(q34;q11.2), 11q23 (MLL) rearrangements, t(1;19)
(q23;p13.3) or t(12;21)(p13;q22) in ALL. Karyotypes from 23
hyperdiploid ALL with more than 50 chromosomes retrieved
from the databases of the Department of Genetics in Pamplona
and the Institute of Human Genetics in Kiel were compared to
the 51 MM cases from the above-described hyperdiploid
myeloma cluster fulfilling the inclusion criteria. Average linkage
hierarchical clustering of the trisomies using Jaccard’s coeffi-
cient resulted in a perfect differentiation between MM and ALL,
(Figure 1b). Hyperdiploid MM were characterized by gains of
chromosomes 3, 5, 7, 9, 11, 15 and 19, whereas hyperdiploid
ALL showed predominately trisomies of chromosomes X, 4, 6, 8,
10, 14, 17, 18, 21 and 22 (Figure 1b). The different patterns of
chromosomal aberrations in hyperdiploid MM and ALL suggest
different but conserved mechanisms to underlie the occurrence
of the trisomies in these disorders. Remarkably, the vast majority
of chromosomes with frequent trisomies in ALL were recurrently
lost in the hypodiploid chromosome cluster in MM. This might
somehow suggest the existence of distinct sets of chromosomes
with regard to chromosomal segregation.
In conclusion, the results presented here confirm in an
independent series the presence of distinct cytogenetic clusters
of MM described by Debes-Marun et al. The highly comparable
results of the present and the published study,1 which were
obtained from independent MM series of more than 250 patients
each from different continents, show the results to be valid. In
the nonhyperdiploid subgroups of MM, the activation of
oncogenes by IG translocations seems to be a major pathogenic
mechanisms. Unfavorable prognostic factors like rearrange-
ments in 14q32, monosomy 13, and 17p deletions and
hypodiploidy3–5 cluster together in the same subset of MM
making it difficult to discern whether the unfavorable outcome is
caused by one or by the conjunction of all these factors at the
same time. The pathogenic mechanisms underlying hyperdi-
ploid MM are hitherto unknown. Nevertheless, the distinct and
widely nonoverlapping patterns of trisomies observed between
MM and ALL patients suggest hyperdiploidy in both diseases to
be caused by different but obviously nonrandom events, which
might influence proper chromosome segregation in B-lympho-
cytes. The delineation of karyotypic patterns using statistical
approaches provides a new perspective for studying cytogenetic
variability and complexity in malignancies. Based on the
statistical descriptions of cytogenetic evolution patterns, the
hypothesis on the underlying cellular defects can be generated,
which may warrant future experimental investigations.
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